What this means
This trial is testing whether a diabetes drug called liraglutide can prevent confusion after heart surgery. It is still recruiting people, so no answer is known yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 60 and over
- Where
- 1 site
The science
- Registered title
- Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
- Trial ID
- NCT06361238 ↗
- Phase
- PHASE 3
- Study type
- interventional
- Conditions
- Delirium, Postoperative
- What is tested
- Liraglutide injection, Placebo injection
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Ages
- 60 Years to no maximum
- Dates
- First posted Apr 11, 2024 · updated Dec 20, 2024
Registry summary
This study aims to clarify the preventive effect of perioperative liraglutide application on postoperative delirium in elderly patients with Type 2 diabetes undergoing cardiac surgery.
Sites (1)
- Wenxue liu, Nanjing, Jiangsu, China